Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...
A common CV risk factor calculator for patients with HIV underestimates risk for Black patients and women, while risk for ...
Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen increasingly throughout 2024. | Revenues in the biopharma industry continued to boom ...
In these turblent economic times, your business reputation has never been more important and is in your control. Focusing on your greatest asset will not only safeguard your good name in ...
Here are five things going on in the community. 1. JAMS for Jim with Mom Andrasik’s Hungarian Cabbage Roll Food Truck. When: 7 p ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results